Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$221.42 - $260.97 $3,099 - $3,653
-14 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$207.01 - $276.09 $3,105 - $4,141
-15 Reduced 51.72%
14 $3,000
Q3 2020

Nov 12, 2020

BUY
$255.65 - $303.1 $3,834 - $4,546
15 Added 107.14%
29 $8,000
Q1 2020

May 15, 2020

BUY
$199.77 - $247.81 $2,796 - $3,469
14 New
14 $3,000
Q4 2018

Feb 14, 2019

SELL
$151.91 - $192.21 $68,359 - $86,494
-450 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$167.73 - $192.74 $75,478 - $86,733
450 New
450 $87,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bdo Wealth Advisors, LLC Portfolio

Follow Bdo Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdo Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bdo Wealth Advisors, LLC with notifications on news.